Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Phase III Study Comparing FTD/TPI Therapy Versus Placebo in Patients Who Are Positive for Blood Circulating Tumor DNA After Curative Resection of Colorectal Cancer
Conditions
Interventions
trifluridine and tipiracil
Placebo
Locations
39
Japan
Aichi Cancer Center Hospital
Nagoya, Aichi-ken, Japan
Chiba Cancer Center
Chiba, Chiba, Japan
National Cancer Center Hospital East
Kashiwa, Chiba, Japan
Shikoku Cancer Center
Matsuyama, Ehime, Japan
University of Fukui Hospital
Yoshida, Fukui, Japan
National Hospital Organization Kyushu Cancer Center
Fukuoka, Fukuoka, Japan
Start Date
July 8, 2020
Primary Completion Date
July 18, 2024
Completion Date
July 18, 2024
Last Updated
January 21, 2026
NCT07541924
NCT06662786
NCT06663319
NCT05239741
NCT06342401
NCT06751329
Lead Sponsor
National Cancer Center Hospital East
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions